PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

234 hedge funds and large institutions have $1.83B invested in Pacific Biosciences in 2022 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 65 increasing their positions, 76 reducing their positions, and 29 closing their positions.

Holders
234
Holders Change
+9
Holders Change %
+4%
% of All Funds
3.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
43
Increased
65
Reduced
76
Closed
29
Calls
$24.6M
Puts
$14.5M
Net Calls
+$10.1M
Net Calls Change
+$18.4M

Top Buyers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$34.5M
2
FCM
2
Farallon Capital Management
California
$32.8M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$43.6M
4
Ameriprise
4
Ameriprise
Minnesota
$13.2M
5
BG
5
Bellevue Group
Switzerland
$53M

Top Sellers

1
JSP
1
Jackson Square Partners
California
$123M
2
AIM
2
ARK Investment Management
Florida
$210M
3
Capital International Investors
3
Capital International Investors
California
$49.9M
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$49.7M
5
DM
5
Deerfield Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BFM
251
Boothbay Fund Management
New York
– -$83K -14,283 Closed
TSS
252
Two Sigma Securities
New York
– -$81K -13,908 Closed
DCM
253
Difesa Capital Management
New York
– -$70K -12,000 Closed
IA
254
Inspire Advisors
Idaho
– -$64K -11,000 Closed
GWM
255
Greenwich Wealth Management
Connecticut
– -$16K -10,200 Closed
BAM
256
Byrne Asset Management
New Jersey
– -$30K -5,140 Closed
HI
257
Hudock Inc
Pennsylvania
– -$23K -4,063 Closed
CWM
258
Castle Wealth Management
Florida
– -$12K -2,000 Closed
TWC
259
TD Waterhouse Canada
Ontario, Canada
– -$5.82K -1,000 Closed
MCA
260
Maryland Capital Advisors
Maryland
– -$1K -199 Closed
7 8 9 10
11